{
  "note_id": "gold_t2dm_002",
  "scenario": "t2dm",
  "persona": "gold",
  "note_text": "**Clinical Note**\n\n**Patient Name:** James Wilson  \n**Date of Visit:** [Insert Date]  \n**Age:** 38  \n**Gender:** Male  \n**Occupation:** Warehouse Worker  \n**BMI:** 32.4  \n\n**Chief Complaint:**  \n\"Diabetes follow-up\"\n\n**History of Present Illness:**  \nJames Wilson is a 38-year-old male with a 3-year history of Type 2 Diabetes Mellitus presenting for routine management. His last HbA1c was 7.8%, showing improvement from 8.2% three months ago. He reports home glucose readings between 160-220 mg/dL fasting and 180-250 mg/dL postprandial. He is currently on Metformin 1000mg twice daily and adheres to this regimen despite occasional gastrointestinal upset. He denies any hypoglycemic episodes. Screening for diabetic complications includes a foot exam today and an eye exam 8 months ago revealing mild retinopathy. He also has controlled hypertension on Lisinopril and hyperlipidemia managed with Atorvastatin. His lifestyle includes a sedentary job, minimal exercise, frequent soda consumption, and struggles with portion control. He experiences occasional erectile dysfunction, likely related to his diabetes.\n\n**Review of Systems:**  \n- **General:** No fever, chills, or fatigue.  \n- **Endocrine:** No polyuria, no polydipsia.  \n- **Neurological:** Reports occasional tingling in feet.  \n- **Ophthalmologic:** No recent visual changes.  \n- **Genitourinary:** Occasional erectile dysfunction.  \n- **Gastrointestinal:** Occasional GI upset from Metformin.  \n- **Respiratory/Cardiovascular:** Denies chest pain, shortness of breath.  \n- **Integumentary:** No skin changes or wounds.  \n\n**Past Medical History:**  \n- Type 2 Diabetes Mellitus  \n- Hypertension  \n- Hyperlipidemia  \n\n**Medications:**  \n- Metformin 1000mg twice daily  \n- Lisinopril 20mg daily  \n- Atorvastatin 20mg daily  \n\n**Allergies:**  \n- No known drug allergies\n\n**Social History:**  \n- Occupation: Warehouse worker  \n- Lifestyle: Sedentary, minimal exercise  \n- Diet: Frequent soda consumption, struggles with portion control  \n- Tobacco/Alcohol: Denies use\n\n**Physical Examination:**  \n- **Vital Signs:** BP 128/78 mmHg, HR 78, Weight 185 lbs, BMI 32.4, Temperature 98.6\u00b0F  \n- **General:** Alert, obese, pleasant  \n- **Cardiovascular:** Regular rate and rhythm, no murmurs, peripheral pulses 2+ dorsalis pedis and posterior tibial bilaterally  \n- **Respiratory:** Clear to auscultation bilaterally  \n- **Extremities:** Monofilament test shows protective sensation intact bilaterally, skin intact without wounds or calluses, no edema, pedal pulses palpable  \n- **Feet:** No deformities, nails trimmed, no fungal infection  \n\n**Assessment and Plan:**  \n1. **Type 2 Diabetes Mellitus, improving control (ICD-10: E11.65):**  \n   - Add Semaglutide 0.25mg subcutaneous weekly, increase to 0.5mg after 4 weeks.  \n   - Continue Metformin 1000mg twice daily.  \n   - Order HbA1c in 3 months.  \n   - Referral to diabetes educator for nutrition counseling.  \n   - Lifestyle counseling: Eliminate sugar-sweetened beverages, portion control, increase physical activity to 150 min/week.  \n   - Weight loss goal: 5-10% body weight over 6 months.  \n   - Patient education on glucose targets and Semaglutide injection technique.  \n\n2. **Obesity (ICD-10: E66.9):**  \n   - Addressed through lifestyle modifications and weight loss goal.  \n\n3. **Essential hypertension, controlled (ICD-10: I10):**  \n   - Continue Lisinopril 20mg daily.  \n\n4. **Hyperlipidemia (ICD-10: E78.5):**  \n   - Continue Atorvastatin 20mg daily.  \n\n5. **Complication screenings:**  \n   - Order annual kidney function tests (BMP, urinalysis with microalbumin).  \n   - Referral to ophthalmology for annual dilated eye exam due to noted mild retinopathy.  \n\n6. **Erectile dysfunction:**  \n   - Discussed potential improvement with better glucose control. Consider PDE5 inhibitors if persistent.  \n\n7. **Vaccinations:**  \n   - Ensure flu vaccine, check pneumococcal status.  \n\n**Time Spent:** 25 minutes with extensive medication counseling and lifestyle education.\n\n**Billing Level:** 99214 (Established patient, moderate to high complexity due to uncontrolled chronic disease)\n\n**Medical Decision Making:**  \nDiscussed the improvement in glycemic control with HbA1c reduction but still above goal, necessitating the addition of Semaglutide for further management. Addressed cardiovascular risk factors and lifestyle barriers. Reviewed and ordered necessary screenings and referrals for comprehensive diabetes management.",
  "demographics": {
    "age": 38,
    "gender": "M",
    "occupation": "warehouse worker",
    "name": "James Wilson"
  },
  "generated_at": "2026-02-14T01:55:59.077924",
  "ground_truth_scores": {
    "completeness": 92,
    "accuracy": 95,
    "compliance": 90,
    "risk": 88,
    "clarity": 93
  }
}